RAPH stock

Raphael Pharmaceutical Inc. (RAPH) financials · $28.2M cap

Raphael Pharmaceutical Inc. (RAPH) $28.2M cap.

Cached annual income statement
LineFY2025FY2024
Revenue$0$0
Cost of Revenue$0$0
Gross Profit$0$0
Operating Income-$1.2M-$1.5M
Net Income-$1.3M-$1.5M
EPS (Diluted)$0.07$0.08
Cached annual balance sheet
LineFY2025FY2024
Total Assets$53.0K$27.0K
Current Assets$51.0K$25.0K
Cash & Equivalents$0$19.0K
Inventory$0$0
PP&E$2.0K$2.0K
Total Liabilities$53.0K$27.0K
Current Liabilities$1.5M$769.0K
Short-term Debt$0$41.0K
Long-term Debt$0$0
Total Debt$0$0
Shareholders' Equity-$1.4M-$742.0K
Retained Earnings-$10.2M-$8.9M
Cached annual cash flow
LineFY2025FY2024
Operating Cash Flow-$210.0K-$532.0K
CapEx$0$0
Investing Cash Flow$0$0
Financing Cash Flow$236.0K$321.0K
Dividends Paid$0$0
Net Change in Cash$0$0
Free Cash Flow$0$0

FAQ

What is RAPH P/E and revenue?

Raphael Pharmaceutical Inc. (RAPH) $28.2M cap.

What is RAPH revenue?

Raphael Pharmaceutical Inc. last cached revenue is $0 (FY2025).

Is RAPH profitable?

Raphael Pharmaceutical Inc. last cached net income is -$1.3M.

What are RAPH total assets?

Raphael Pharmaceutical Inc. last cached total assets are $53.0K.

What is RAPH free cash flow?

Raphael Pharmaceutical Inc. last cached free cash flow is $0.

Not investment advice. Cached statements, not a live tape.